Milestone Pharmaceuticals Q1 EPS $(0.31) Misses $(0.18) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.18) by 72.22 percent. This is a 47.62 percent decrease over losses of $(0.21) per
Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.18) by 72.22 percent. This is a 47.62 percent decrease over losses of $(0.21) per share from the same period last year.